Literature DB >> 1676526

Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats.

L A Marco1, R S Joshi, R B Chronister.   

Abstract

The effects of MK-801 at doses from 0.005 to 1 mg/kg IP on linguopharyngeal events (protrusions, retrusions and swallows) were determined in rats to find out whether MK-801 resembles ketamine in its capacity to increase the frequency of recurrence of such events that we have demonstrated in previous studies. All rats receiving a dose of 0.05 mg/kg or higher showed an increase in linguopharyngeal event frequency within 5 min and this enhancement (3-fold from baseline level) was maintained for longer than 1 h. At the lowest dose of 5 micrograms/kg the effect lasted only very briefly. A general increase in motor behavior was also observed within 10 min of drug administration. More complex patterns of motor behavior, consisting of stereotypical head bobbing, paw movements reminiscent of walking activity, nystagmus, and ataxia were observed with doses of 0.25 mg/kg and higher. All rats showed a marked startle response at early stages post-injection and hypersensitivity to external stimuli such as noise or movement in the room. However, there was an absolute lack of coordinated avoidance responses normally associated with such startle responses or arousing stimuli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676526     DOI: 10.1007/bf02244245

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Phencyclidine.

Authors:  S H Snyder
Journal:  Nature       Date:  1980-06-05       Impact factor: 49.962

2.  Behavioral effects of MK-801 in the rat.

Authors:  D F Wozniak; J W Olney; L Kettinger; M Price; J P Miller
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics.

Authors:  J W Olney; M T Price; T A Fuller; J Labruyere; L Samson; M Carpenter; K Mahan
Journal:  Neurosci Lett       Date:  1986-07-11       Impact factor: 3.046

4.  A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats.

Authors:  W Koek; J H Woods; P Ornstein
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

Authors:  R P Simon; J H Swan; T Griffiths; B S Meldrum
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

6.  Functional evidence for PCP-like effects of the anti-stroke candidate MK-801.

Authors:  M F Piercey; W E Hoffmann; P Kaczkofsky
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex.

Authors:  N L Harrison; M A Simmonds
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

8.  Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist.

Authors:  T Wieloch
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

9.  Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate.

Authors:  W Koek; J H Woods; P Ornstein
Journal:  Life Sci       Date:  1986-09-15       Impact factor: 5.037

10.  Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate.

Authors:  W Koek; E Kleer; P J Mudar; J H Woods
Journal:  Behav Brain Res       Date:  1986-03       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.